News & Press Releases
SET Announcements
Exercise of Shareholders' Rights to Propose Agenda for the 2027 Annual General Meeting of Shareholders and Nominate a person to be elected as a director of the Company in advance
Read the full announcement on the SET website ↗Management Discussion and Analysis Quarter 3 Ending 30 Sep 2026
Read the full announcement on the SET website ↗Financial Performance Quarter 3 (F45) (Reviewed)
Read the full announcement on the SET website ↗Financial Statement Quarter 3/2026 (Reviewed)
Read the full announcement on the SET website ↗Notification on Receipt of the Report on the Result of the Securities Acquisition of Bioscience Animal Health Public Company Limited (Form 256-2)
Read the full announcement on the SET website ↗Amendment to the Opinion of Bioscience Animal Health Public Company Limited on the Tender Offer for Securities (Form 250-2) and Opinion of the Independent Financial Advisor (Revised No.2)
Read the full announcement on the SET website ↗Notification on Receipt of the Report on the Preliminary Result of the Tender Offer for Securities of Bioscience Animal Health Public Company Limited (Form 247-6-Khor)
Read the full announcement on the SET website ↗Amendment to the Opinion of Bioscience Animal Health Public Company Limited on the Tender Offer for Securities (Form 250-2) and Opinion of the Independent Financial Advisor (Revised No.1)
Read the full announcement on the SET website ↗Notification on Receipt of the Amendment to the Tender Offer (Form 247-4) (Revised No.2)
Read the full announcement on the SET website ↗Submission of Bioscience Animal Health Public Company Limited's Opinion on the Tender Offer (Form 250-2) and the Independent Financial Advisor's Opinion
Bioscience Animal Health Public Company Limited (BIS) has submitted its opinion on the tender offer (Form 250-2) and the independent financial advisor's opinion. The offerors are Mrs. Phatcharee Nanthawatsiri, Mr. Sarawut Techasattaya, and Mrs. Rungnapa Techasattaya at a net price of 1.2666 baht per share. The tender offer period runs from 25-Sep-2026 to 03-Nov-2026, with payment settlement on 05-Nov-2026.
Summarised automatically from the announcement filed with SET.
Read the full announcement on the SET website ↗Notification on Receipt of the Amendment to the Tender Offer (Form 247-4) (Revised No.1)
The offerors, Mrs. Phatcharee Nanthawatsiri, Mr. Sarawut Techasattaya and Mrs. Rungnapa Tachasattaya, reported the amendment to the tender offer for Bioscience Animal Health Public Company Limited (BIS). The tender offer period is from 25-Sep-2026 to 03-Nov-2026 at an offer price of 1.27 baht per share, with a net price of 1.2666 baht per share. The tender is not for delisting, and the securities payment settlement will occur on 05-Nov-2026.
Summarised automatically from the announcement filed with SET.
Read the full announcement on the SET website ↗Notification on the Receipt of Tender Offer for the Securities (Form 247-4)
Mrs. Phatcharee Nanthawatsiri, Mr. Sarawut Techasattaya and Mrs. Rungnapa Tachasattaya have submitted a tender offer for shares of Bioscience Animal Health Public Company Limited (BIS) at 1.27 baht per share (net price 1.2666 baht per share). The tender offer period runs from 25-Sep-2026 to 03-Nov-2026, with payment settlement on 05-Nov-2026. The offer is for cash and is not for delisting. Globlex Securities Company Limited is the tender offer agent.
Summarised automatically from the announcement filed with SET.
Read the full announcement on the SET website ↗Notification of the Board of Directors' Resolutions Regarding the Receipt of Form 247-3, the Appointment of an IFA to Provide an Opinion on the Tender Offer and the appointment of a director to replace a director who has vacated
Bioscience Animal Health Public Company Limited (BIS) received a tender offer from Mrs. Phatcharee Nanthawatsiri, Mr. Sarawut Techasattaya, and Mrs. Rungnapa Tachasattaya at a cash offer price of 1.27 baht per share and a net price of 1.2666 baht per share. The tender offer is not for delisting, and Globlex Securities Company Limited is the tender offer agent. Separately, Mr. Seksom Attamangkune was appointed as a director of BIS, effective September 11, 2026.
Summarised automatically from the announcement filed with SET.
Read the full announcement on the SET website ↗
